Product Images Irinotecan Hydrochloride 40 Mg/2 Ml

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Irinotecan Hydrochloride 40 Mg/2 Ml NDC 72485-211 by Armas Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image description - Fig3

image description - Fig3

This is a figure (Figure 3) showing survival probability for second-line treatment with Irinotecan compared to best supportive care in a study (Study 7). It includes data on the number of patients (N), median follow-up time in months, and median survival in months for both treatments. The *log-rank test was used.*

image description - Fig4

image description - Fig4

image description - label1.2

image description - label1.2

This is a description of a medication called Irinotecan, which is a cytotoxic agent used for intravenous injection. Each mL contains 20 mg of irinotecan hydrochloride, USP, 45 mg of sonvitol [rinotecan Hydrochloride powder, and other ingredients. The dosage information for the medication should be obtained from the accompanying prescribing information. The product is manufactured by Shilpa Medicare Limited in India and distributed by Armas Pharmaceuticals in the USA. It comes in a single-dose vial of 2 mL, and any unused portion should be discarded. The medication should be stored at 20° to 25°C (68° to 77°F), protected from light and freezing.*

image description - structure

image description - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.